×
For best experience we recommend to activate Javascript in your browser.
Recombinant ErbB3 (Lumretuzumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-ErbB3 (Lumretuzumab Biosimilar) antibody is suitable to detect ErbB3 (Lumretuzumab Biosimilar) in samples from Human. It has been validated for ELISA.
Catalog No. ABIN7488048
$336.06
Plus shipping costs $50.00
1 mg ABIN7446050
100 μg ABIN7488048
1 mg ABIN7446050
100 μg ABIN7488048
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant ErbB3 (Lumretuzumab Biosimilar) antibody (ABIN7488048)
Target
ErbB3 (Lumretuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for ErbB3 (Lumretuzumab Biosimilar) antibodies
Mammalian Cells
Clonality
All clonalities for ErbB3 (Lumretuzumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for ErbB3 (Lumretuzumab Biosimilar) antibodies
This ErbB3 (Lumretuzumab Biosimilar) antibody is un-conjugated
Application
All applications for ErbB3 (Lumretuzumab Biosimilar) antibodies
ELISA
Grade
Research Grade
Product Details anti-ErbB3 (Lumretuzumab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Lumretuzumab Biosimilar - Anti-ERBB3 mAb
Characteristics
Antibody Type: IgG1-kappa
Purification
Recombinant antibody expressed in mammalien cells and purified.
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Buffer
PBS pH 7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target Details for ErbB3 (Lumretuzumab Biosimilar)
(hide)
Target
ErbB3 (Lumretuzumab Biosimilar)
Target Type
Biosimilar
Background
RG-7116,RO5479599 Lumretuzumab is a humanized monoclonal antibody designed for the treatment of cancer.
CAS-No
1448327-63-6
Recently viewed
(hide)
Chat with us , powered by LiveChat